M. Skokan

发表

Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

F. Cappuzzo, M. Varella‐Garcia, R. Doebele, 2012, Clinical Cancer Research.

Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients

M. Alloisio, L. Terracciano, M. Skokan, 2008 .

Native and rearranged ALK copy number and rearranged cell count in non–small cell lung cancer

W. Franklin, M. Varella‐Garcia, R. Doebele, 2013, Cancer.

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

P. Jänne, F. Cappuzzo, G. Finocchiaro, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

EGFR-related genomic abundance associates with EGFR mutation in non-small cell lung cancer and is accurately detected by interphase FISH

J. Minna, A. Gazdar, P. Bunn, 2006 .

Fluorescence in situ hybridization (FISH) subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in NSCLC

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2007 .

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.

A. Marchetti, F. Buttitta, F. Cappuzzo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.

M. Varella‐Garcia, M. Skokan, Mark Jones, 2013, Cytotherapy.

Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.

M. Skokan, J. Harral, K. Stenmark, 2008, American journal of physiology. Lung cellular and molecular physiology.

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

P. Jänne, F. Cappuzzo, A. Holmes, 2008, British Journal of Cancer.

Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease

P. Jänne, M. Scorsetti, M. Varella‐Garcia, 2014, PloS one.

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer

M. Varella‐Garcia, R. Doebele, A. Baron, 2012, Cancer.

Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.

F. Cappuzzo, F. Hirsch, T. Boggon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study

M. Moroni, V. Torri, F. Cappuzzo, 2011, Journal of Clinical Pathology.

Fluorescence In situ Hybridization Subgroup Analysis ofTRIBUTE , a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non ^ Small Cell Lung Cancer

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2008 .

EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort

F. Hirsch, T. Mitsudomi, P. Bunn, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Fluorescence In situ Hybridization Subgroup Analysis of TRIBUTE, a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non–Small Cell Lung Cancer

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2008, Clinical Cancer Research.